MYGN Stock Summary and Trading Ideas (Myriad Genetics | NASDAQ:MYGN)

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

What symbol and exchange does Myriad Genetics shares trade?

Myriad Genetics trades on the NASDAQ stock market under the symbol MYGN.

What is Myriad Genetics stock price doing today?

As of June 5, 2026, MYGN stock price declined to $4.57 with 1,108,532 million shares trading.

What is Myriad Genetics's Beta?

MYGN has a beta of 2.58, meaning it tends to be more sensitive to market movements. MYGN has a correlation of 0.15 to the broad based SPY ETF.

How much is Myriad Genetics worth?

MYGN has a market cap of $431.60 million. This is considered a Small Cap stock.

How much money does Myriad Genetics make?

Last quarter Myriad Genetics reported $200 million in Revenue and -$.09 earnings per share. This fell short of revenue expectation by $-2 million and met earnings estimates .

What is the highest and lowest price Myriad Genetics traded in the last 3 year period?

In the last 3 years, MYGN traded as high as $29.30 and as low as $3.53.

What are the top ETFs holding Myriad Genetics?

The top ETF exchange traded funds that MYGN belongs to (by Net Assets): VTI, XBI, IWM, VXF, IWN.

Is Myriad Genetics (MYGN) a good investment?

MYGN has underperformed the market in the last year with a return of -7.1%, while the SPY ETF gained +25.6%. In the last 3 month period, MYGN fell short of the market, returning -10.9%, while SPY returned +8.5%. However, in the most recent 2 weeks MYGN has outperformed the stock market by returning +19.6%, while SPY returned -1.1%.

What are the support and resistance levels for Myriad Genetics (MYGN)?

MYGN support price is $4.47 and resistance is $4.91 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MYGN shares will trade within this expected range on the day.